Chapter 16 Treatment of Infertility and Early Pregnancy Loss in the Antiphospholipid Syndrome

Handbook of Systemic Autoimmune Diseases

Volumn 10, Issue , 2009, Pages 193-201

  Balasch, Juan ^a   Carmona, Francisco ^a   Creus, Montserrat ^a   Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

abortion; antiphospholipid syndrome; infertility; miscarriage; pregnancy loss

Indexed keywords

EID: 67649653614     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(08)00416-9     Document Type: Review

References (48)

1. Alarcón-Segovia D., Boffa M.C., Branch W., Cervera R., Gharavi A., Khamashta M., Shoenfeld Y., Wilson W., and Roubey R. Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12 (2003) 499-503
2. American Society for Reproductive Medicine. 1999. Antiphospholipid antibodies do not affect IVF success. A Practice Committee Report, October.
3. Balasch J., Carmona F., Creus M., Font J., and Cervera R. Management of reproductive failure in the antiphospholipid syndrome. In: Asherson R.A., Cervera R., Piette J.C., and Shoenfeld Y. (Eds). The Antiphospholipid Syndrome II-Autoimmune Thrombosis (2002), Elsevier, Amsterdam 375-394
4. Balasch J., Carmona F., López-Soto A., Cervera R., Jové I., Casals F.J., and Vanrell J.A. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum. Reprod. 8 (1993) 2234-2239
5. Balasch J., Creus M., Fábregues F., Cívico S., Reverter J.C., Carmona F., Tàssies D., and Vanrell J.A. Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Hum. Reprod. 13 (1998) 1180-1183
6. Balasch J., Creus M., Fábregues F., Reverter J.C., Carmona F., Tàssies D., Font J., and Vanrell J.A. Antiphospholipid antibodies and human reproductive failure. Hum. Reprod. 11 (1996) 2310-2315
7. Balasch J., Font J., López-Soto A., Cervera R., Jové I., Casals F.J., and Vanrell J.A. Antiphospholipid antibodies in unselected patients with repeated abortion. Hum. Reprod. 5 (1990) 43-46
8. Birkenfeld A., Mukaida T., Minichiello L., Jackson M., Kase N.G., and Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am. J. Reprod. Immunol. 31 (1994) 65-68
9. Branch D.W., and Silver R.M. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss. Lupus 5 (1996) 409-413
10. Carmona F., Font J., Azulay M., Creus M., Fábregues F., Cervera R., Puerto B., and Balasch J. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am. J. Reprod. Immunol. 46 (2001) 274-279
11. Carp H.J., and Shoenfeld Y. Anti-phospholipid antibodies and infertility. Clin. Rev. Allergy Immunol. 32 (2007) 159-161
12. Cervera R., and Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum. Reprod. Update 14 (2008) 359-366
13. Christiansen O.B. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women. BMJ 315 (1997) 372
14. Coomarasamy A., Papaioannou S., Gee H., and Khan K.S. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery doppler: A meta-analysis. Obstet. Gynecol. 98 (2001) 861-866
15. Coulam C.B., Branch D.W., Clark D.A., Gleicher N., Kutteh W., Lockshin M.D., and Rote N.S. American Society for Reproductive Immunology Report of the Committee for establishing criteria for diagnosis of reproductive autoimmune syndrome. Am. J. Reprod. Immunol. 41 (1999) 121-132
16. Derksen R.H.W., De Groot Ph.G., Nieuwenhuis H.K., and Christiaens G.C. How to treat women with antiphospholipid antibodies in pregnancy?. Ann. Rheum. Dis. 60 (2001) 1-3
17. Ginsberg J.S., and Hirsh J. Use of antithrombotic agents during pregnancy. Chest 114 (1998) 524S-530S
18. Greaves M. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation. Haemostasis 30 Suppl. 2 (2000) 16-25
19. Greaves M., Cohen H., Machin S.J., and Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br. J. Haematol. 109 (2000) 704-715
20. Hachulla E., Piette A.M., Hatron P.Y., and Blétry O. Aspirin and antiphospholipid syndrome. Rev. Med. Interne 21 Suppl. 1 (2000) 83s-88s
21. Harger J.H., Archer D.F., Marchese S.G., Muracca-Clemens M., and Garver K.L. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet. Gynecol. 62 (1983) 574-581
22. Hatasaka H.H., Branch D.W., Kutteh W.H., and Scott J.R. Autoantibody screening for infertility: explaining the unexplained?. J. Reprod. Immunol. 34 (1997) 137-153
23. Hornstein M.D., Davis O.K., Massey J.B., Paulson R.J., and Collins J.A. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil. Steril. 73 (2000) 330-333
24. Khamashta M.A. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 7 Suppl. 2 (1998) S162-S165
25. Krause I., Blank M., Gilbrut B., and Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am. J. Reprod. Immunol. 29 (1993) 155-161
26. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet. Gynecol. 174 (1996) 1584-1589
27. Kutteh W.H., Rote N.S., and Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am. J. Reprod. Immunol. 41 (1999) 133-152
28. Kutteh W.H., Yetman D.L., Chantiles S.J., and Crain J. Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Hum. Reprod. 12 (1997) 1171-1175
29. Le Thi Huong D., Wechsler B., Bletry O., Vauthier-Brouzes D., Lefebvre G., and Piette J.C. A study of 75 pregnancies in patients with antiphospholipid syndrome. J. Rheumatol. 28 (2001) 2025-2030
30. Lima F., Khamashta M.A., Buchanan N.M.M., Kerslake S., Hunt B.J., and Hughes G.R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 14 (1996) 131-136
31. Lockshin M.D. Pregnancy loss in the antiphospholipid syndrome. Thromb. Haemost. 82 (1999) 641-648
32. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H.W.M., De Groot P.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., and Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4 (2006) 295-306
33. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddell H.S., and McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am. J. Obstet. Gynecol. 183 (2000) 1008-1012
34. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 (1997) 253-257
35. Rosove M.H., Tabsh K., Wasserstrum N., Howard P., Hahn B.H., and Kalunian K.C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet. Gynecol. 75 (1990) 630-634
36. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R.V. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome. Lupus 10 (2001) 241-245
37. Sanson B.J., Lensing A.W., Prins M.H., Ginsberg J.S., Barkagan Z.S., Lavenne-Pardonge E., Brenner B., Dulitzky M., Nielsen J.D., Boda Z., Turi S., Mac Gillavry M.R., Hamulyák K., Theunissen I.M., Hunt B.J., and Büller H.R. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb. Haemost. 81 (1999) 668-672
38. Schenk, L.M., Butler, L., Morris, J.P. 1996. Heparin and aspirin treatment yieds higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. American Society of Reproductive Medicine Meeting. November, Boston, MA, USA. Abstract O-076.
39. Selva-O'Callaghan A., Ordi-Ros J., Monegal-Ferran F., Martinez N., Cortes-Hernandez F., and Vilardell-Tarres M. IgA anticardiolipin antibodies-relation with other antiphospholipid antibodies and clinical significance. Thromb. Haemost. 79 (1998) 282-285
40. Shah N.M., Khamashta M.A., Atsumi T., and Hughes G.R.V. Outcome of patients with anticardiolipin antibodies: a 10 years follow-up of 52 patients. Lupus 7 (1998) 3-6
41. Sher G., Feinman M., Zouves C., Kuttner G., Maassarani G., Salem R., Matzner W., Ching W., and Chong P. High fecundity rates following antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod. 9 (1994) 2278-2283
42. Shoenfeld Y., Blank M., and Shere Y. Induction and treatment of the antiphospholipid syndrome-lessons from animal models. Eur. J. Clin. Invest. 31 (2001) 736-740
43. Silver R.K., MacGregor S.N., Sholl J.S., Hobart J.M., Neerhof M.G., and Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am. J. Obstet. Gynecol. 169 (1993) 1411-1417
44. Silver R.M., Porter T.F., Van Leeuween I., Jeng G., Scott J.R., and Branch D.W. Anticardiolipin antibodies: clinical consequences of "low titers". Obstet. Gynecol. 87 (1996) 494-500
45. Stray-Pedersen B., and Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol. 148 (1984) 140-146
46. Tincani A., Branch W., Levy R.A., Piette J.C., Carp H., Rai R.S., Khamashta M., and Shoenfeld Y. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12 (2003) 524-529
47. Udoff L.C., and Branch D.W. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J. Autoimmun. 15 (2000) 209-211
48. Vinatier D., Dufour P., Cosson M., and Houpeau J.L. Antiphospholipid syndrome and recurrent miscarriage. Eur. J. Obstet. Gynecol. 96 (2001) 37-50